Member of Lyonbiopole
Averoa, "the smart drug incubator", is dedicated to developing and registering drugs in the field of kidney disease.
Our expertise lies in identifying innovative products with the potential to meet major medical needs and enabling them to reach a stage of development to maximise their therapeutic and commercial value.
Application market: Metabolic Disorders - Endocrinology, Rare disease
Type of activity: Medical device, Therapeutics, Pharma or Biotech
Technologies: Small Molecules
Created on dec. 22nd, 2021 - 5 employees
Address
11 Avenue Paul Verlaine 38100 Grenoble
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.